Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-03

Clinical Trial Update: Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating brain imaging with nuclear technology in individuals with Parkinson's disease and Parkinsonian syndrome completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institute for Neurodegenerative Disorders | Conditions: Parkinson's Disease, Parkinsonian Syndrome | Phase 2 | Status: COMPLETED